(Q35124558)

6 August 2017

Adjuvant ovarian suppression in premenopausal breast cancer (English)

1 reference

6 August 2017

1 reference

26

Giuseppe Viale

1 reference

6 August 2017

10

Harold J Burstein

1 reference

6 August 2017

28

Aron Goldhirsch

1 reference

6 August 2017

2

Meredith M Regan

1 reference

6 August 2017

18

James N Ingle

1 reference

6 August 2017

1

Prudence A Francis

1 reference

6 August 2017

5

Eva Ciruelos

1 reference

6 August 2017

14

Barbara A Walley

1 reference

6 August 2017

3

Gini F Fleming

1 reference

6 August 2017

25

Marco Colleoni

1 reference

6 August 2017

4

István Láng

1 reference

6 August 2017

7

Hervé R Bonnefoi

1 reference

6 August 2017

11

Silvana Martino

1 reference

6 August 2017

13

Charles E Geyer

1 reference

6 August 2017

19

Eric P Winer

1 reference

6 August 2017

Manuela Rabaglio-Poretti

20

object named as

Manuela Rabaglio-Poretti

1 reference

6 August 2017

22

Barbara Ruepp

1 reference

6 August 2017

23

Anita Giobbie-Hurder

1 reference

6 August 2017

24

Karen N Price

1 reference

International Breast Cancer Study Group

6 August 2017

31

object named as

International Breast Cancer Study Group

1 reference

6 August 2017

6

Meritxell Bellet

1 reference

6 August 2017

8

Miguel A Climent

1 reference

6 August 2017

12

Nancy E Davidson

1 reference

6 August 2017

17

Stefan Buchholz

1 reference

6 August 2017

Gian Antonio Da Prada

9

1 reference

6 August 2017

Robert Coleman

15

1 reference

6 August 2017

Pierre Kerbrat

16

1 reference

6 August 2017

Rudolf Maibach

21

1 reference

6 August 2017

Alan S Coates

27

1 reference

6 August 2017

Richard D Gelber

29

1 reference

6 August 2017

SOFT Investigators

30

1 reference

6 August 2017

language of work or name

English

0 references

publication date

11 December 2014

1 reference

The New England Journal of Medicine

6 August 2017

1 reference

6 August 2017

372

1 reference

6 August 2017

5

1 reference

6 August 2017

436-446

1 reference

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

First international consensus guidelines for breast cancer in young women (BCY1).

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Adjuvant therapy for very young women with breast cancer: need for tailored treatments

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4341825

Amenorrhea from Breast Cancer Therapy — Not a Matter of Dose

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25495490

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1412379

1 reference

6 August 2017

1 reference

6 August 2017

1 reference